MIS
IONS icon

Morningstar Investment Services’s Ionis Pharmaceuticals IONS Stock Holding History

Morningstar Investment Services’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-222,681
Closed -$8M – 228
2022
Q1 		$8M Buy
222,681
+3,249
+1% +$106K 0.09% 125
2021
Q4 		$6.68M Buy
219,432
+5,291
+2% +$167K 0.07% 130
2021
Q3 		$7.21M Buy
214,141
+4,034
+2% +$152K 0.09% 121
2021
Q2 		$8.31M Buy
210,107
+7,400
+4% +$290K 0.1% 118
2021
Q1 		$9.06M Buy
+202,707
New +$11.3M 0.12% 119

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morningstar Investment Services's IONS Position: Q2 2022 in Review

Morningstar Investment Services sold out of Ionis Pharmaceuticals (IONS) in Q2 2022, closing a stake of 222,681 shares — an estimated $8M sold.

Morningstar Investment Services first reported a position in IONS in Q1 2021 and held it in 5 quarters. The position peaked at $9.06M in Q1 2021. 349 funds tracked by Wall St. Rank hold IONS as of Q2 2022.

  • Morningstar Investment Services reported no remaining Ionis Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Morningstar Investment Services sold 222,681 Ionis Pharmaceuticals shares in Q2 2022, an estimated $8M.
  • Morningstar Investment Services first reported a position in Ionis Pharmaceuticals in Q1 2021 and held it in 5 quarters.
  • Morningstar Investment Services's Ionis Pharmaceuticals position peaked at $9.06M in Q1 2021.
  • 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2022.

Based on Morningstar Investment Services's 13F filing for Q2 2022, filed 12 Aug 2022.